Form 4: Abbott Laboratories Director Michael O'Grady Reports Stock and Option Awards

Director Michael O'Grady reports acquisition of restricted stock units and stock options in Abbott Laboratories under the 2017 Incentive Stock Program.

Summary

• On April 26, 2024, Michael O'Grady, a director of Abbott Laboratories, reported the acquisition of 1,866 common shares without par value and 4,404 stock options.
• The common shares were acquired as restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program.
• These restricted stock units will be paid in Abbott common shares on a one-to-one basis upon separation from service, death, or a change in control.
• The stock options, also granted under the 2017 Incentive Stock Program, have an exercise price of $107.14 and expire on April 25, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The filing indicates standard compensation practices and alignment of director interests with shareholders, which is generally viewed favorably.

Positives

• The acquisition of stock options and restricted stock units by a director signals confidence in the company's future performance.
• The incentive stock program aligns the director's interests with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements, but the stock and option awards suggest an expectation of continued growth and profitability for Abbott Laboratories.

Industry Context

Stock and option awards are a common practice in the pharmaceutical industry to incentivize executives and align their interests with those of shareholders. This filing reflects standard compensation practices for directors at large, publicly traded companies like Abbott Laboratories.

Comparison to Industry Standards

• Stock option grants to directors are a common practice among large pharmaceutical companies such as Johnson & Johnson (JNJ) and Pfizer (PFE).
• The terms of Abbott's 2017 Incentive Stock Program are likely comparable to similar programs at peer companies, offering a mix of stock options and restricted stock units.
• Director compensation packages typically include a base salary, stock options, and restricted stock units, aligning their interests with long-term shareholder value.

Stakeholder Impact

• The stock and option awards align the director's interests with those of shareholders, potentially leading to decisions that increase shareholder value.
• The awards serve as an incentive for the director to contribute to the company's success.

Key Dates